| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $221.2M | — | +74.4% |
| Cost of Revenue | $75.7M | — | +123.1% |
| Gross Profit | $145.5M | — | +56.6% |
| R&D Expense | $57.0M | — | +52.5% |
| SG&A Expense | $33.3M | — | +15.4% |
| Operating Income | $9.0M | — | +26.9% |
| Pre-tax Income | -$3.6M | — | -142.5% |
| Income Tax | -$809K | — | -152.2% |
| Net Income | -$2.8M | — | -142.6% |
| EPS (Basic) | -$0.01 | — | -133.3% |
| EPS (Diluted) | -$0.01 | — | -133.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $81.5M | -10.7% | -70.4% |
| Short-term Investments | $0 | — | -100.0% |
| Accounts Receivable | $169.6M | +1.4% | +52.2% |
| Current Assets | $294.2M | -0.4% | -30.3% |
| Total Assets | $3.03B | -0.2% | +135.5% |
| Current Liabilities | $130.5M | -19.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.7M | — | -27.9% |
| Capital Expenditures | $6.4M | — | +338.7% |
| Investing Cash Flow | -$6.4M | — | -106.5% |
| Financing Cash Flow | -$19.2M | — | +29.4% |
| Free Cash Flow | $11.2M | — | -51.2% |
| +57.3% |
| Long-term Debt | $806.4M | -2.0% | — |
| Total Liabilities | $972.3M | -2.9% | +581.3% |
| Stockholders' Equity | $2.05B | +1.4% | +83.7% |